Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
Daly Jason B. (CIK 1906486) reported 13 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-13). Recent activity: Sell AMRX (6,613 shares), Sell AMRX (210,000 shares), Buy AMRX (22,645 shares), Sell AMRX (10,147 shares), Buy AMRX (38,226 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-13 | Amneal Pharmaceuticals, Inc. (AMRX) | EVP, Chief Legal Officer | Sell | 6,613 | $117,050 |
| 2026-08-13 | Amneal Pharmaceuticals, Inc. (AMRX) | EVP, Chief Legal Officer | Sell | 210,000 | $3.7M |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | EVP, Chief Legal Officer | Buy | 22,645 | $0 |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | EVP, Chief Legal Officer | Sell | 10,147 | $135,057 |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | EVP, Chief Legal Officer | Buy | 38,226 | $0 |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | EVP, Chief Legal Officer | Sell | 16,598 | $220,919 |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | EVP, Chief Legal Officer | Buy | 24,258 | $0 |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | EVP, Chief Legal Officer | Sell | 10,533 | $140,194 |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | EVP, Chief Legal Officer | Buy | 305,810 | $0 |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | EVP, Chief Legal Officer | Sell | 132,783 | $1.8M |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | EVP, Chief Legal Officer | Buy | 35,880 | $0 |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | EVP, Chief Legal Officer | Sell | 15,580 | $207,214 |
| 2025-08-13 | Amneal Pharmaceuticals, Inc. (AMRX) | EVP, Chief Legal Officer | Sell | 22,000 | $199,100 |
Source: SEC Form 4 filings · as of 2026-08-13